Cleo
PrivateLast Round
Series C
Mar 30, 2021
Est. Valuation
$115M
Total Funding Raised
$80.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cleo operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Series C round in March 2021.
Cleo is a digital health company that provides a holistic family benefits platform to support employees through various life stages, including family planning, parenting, and eldercare.
Sector
Healthcare & Life Sciences
Verticals
HR, Telemedicine, Patient Engagement
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cleo Comparables
Compare Cleo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cariloop | 85% | |
| Wellthy | 85% | |
| Maven Clinic | 80% |
For institutional investors. Book with your work email.
Cleo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 30, 2021 | ||||
| Series B | Mar 20, 2019 | ||||
| Series A | Jun 13, 2018 | ||||
| Seed | Mar 2, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cleo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Notable Capital | Series C |
| Greylock Partners | Series C, Series A |
| New Enterprise Associates | Series C, Series B |
| Forerunner Ventures | Series A, Seed |
| Gaingels | Series C |
| Glynn Capital | Series C |
| PruVen Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 2, 2026
Grew 32% QoQ, from 84 to 111 employees.
- Mar 30, 2021
$40M round led by Leerink Transformation Partners and Transformation Capital.
For institutional investors. Book with your work email.
Cleo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cleo's valuation, stock price, and market status.
Is Cleo a public or private company?
Cleo is a private company.
What is the current stock price of Cleo?
Cleo is a private company, so its shares have no public market price. Caplight tracks Cleo's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cleo worth (valuation)?
Cleo's valuation is estimated at $115.0M based on funding round data.
Can I buy Cleo stock?
Cleo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cleo's last funding round?
Cleo's most recent funding round was Series C on March 30, 2021.
Who are the main investors in Cleo?
Key investors in Cleo include Greylock Partners, New Enterprise Associates, Forerunner Ventures, Felicis Ventures, Leerink Transformation Partners.
Will Cleo IPO soon?
No public IPO plans have been announced for Cleo.
How can I track Cleo secondary market activity?
Caplight tracks bids, offers, and trades in Cleo's shares on secondary markets.